Get the latest tech news
Off-the-Shelf Stem Cell Therapy Reduces Pain by 58%, Regenerates Cartilage
A clinical trial of a novel off-the-shelf stem cell therapy for knee osteoarthritis has shown significant improvements in pain relief and joint function, offering hope for patients suffering from this degenerative condition. The treatment, developed by the Australian biotech company Magellan Stem Cells, demonstrated its potential to halt disease progression with just a single injection.
A clinical trial of a novel off-the-shelf stem cell therapy for knee osteoarthritis has shown significant improvements in pain relief and joint function, offering hope for patients suffering from this degenerative condition. At MD Anderson Cancer Center, a patient achieved complete remission from AML after undergoing a stem cell transplant following chemotherapy and a clinical trial with a targeted drug. This study, conducted in Germany, assessed pregnancy-related outcomes and found that despite the intensive conditioning regimens required for transplantation, a significant number of women were able to conceive and carry pregnancies to term.
Or read this on r/technology
